N dementia cases/Total | HR (95% CI) | p-value for HR comparisonc | C-statistic (95% CI) | p-value for C-statistic comparisond | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Reference group | High-risk group | Model 1a | Model 2b | |||||||
WHITEHALL II | ||||||||||
Median follow-up 22.6 (IQR 19.1, 27.7) years | ||||||||||
Metabolic syndrome (≥ 3 cardiometabolic components)e | ||||||||||
Original MetS definition | 435/4,669 | 87/946 | 1.16 (0.92, 1.47) | 1.15 (0.91, 1.44) | 0.19 | 0.573 (0.545, 0.601) | 0.69 | |||
Revised MetS definitionf | 422/4,999 | 100/1,038 | 1.26 (1.01, 1.57) | 1.22 (0.98, 1.52) | 0.574 (0.546, 0.602) | |||||
Increment of 1 cardiometabolic componentg | ||||||||||
Original MetS definition | 522/6,137 | 1.07 (0.99, 1.15) | 1.06 (0.98, 1.14) | < 0.01 | 0.574 (0.547, 0.602) | 0.64 | ||||
Revised MetS definitionf | 522/6,137 | 1.12 (1.04, 1.20) | 1.11 (1.03, 1.19) | 0.576 (0.548, 0.604) | ||||||
UK BIOBANK | ||||||||||
Median follow-up 13.8 (IQR 13.0, 14.4) years | ||||||||||
Metabolic syndrome (≥ 3 cardiometabolic components)e | ||||||||||
Original MetS definition | 170/103,165 | 248/68,721 | 1.38 (1.13, 1.68) | 1.31 (1.08, 1.60) | 0.01 | 0.630 (0.601, 0.659) | 0.04 | |||
Revised MetS definitionh | 165/103,647 | 253/68,239 | 1.56 (1.28, 1.90) | 1.49 (1.22, 1.83) | 0.637 (0.608, 0.666) | |||||
Increment of 1 cardiometabolic componentg | ||||||||||
Original MetS definition | 418/171,886 | 1.18 (1.10, 1.27) | 1.16 (1.08, 1.25) | < 0.01 | 0.637 (0.608, 0.665) | 0.21 | ||||
Revised MetS definitionh | 418/171,886 | 1.23 (1.14, 1.33) | 1.21 (1.12, 1.30) | 0.640 (0.611, 0.668) |